行情

PRPH

PRPH

Prophase Lab
NASDAQ

实时行情|Nasdaq Last Sale

1.800
-0.095
-5.02%
已收盘, 16:00 04/02 EDT
开盘
1.820
昨收
1.895
最高
1.900
最低
1.800
成交量
1,865
成交额
--
52周最高
2.774
52周最低
1.443
市值
2,084.75万
市盈率(TTM)
-6.6989
分时
5日
1月
3月
1年
5年

PRPH 新闻

更多
  • 自曝造假22亿,市值一夜蒸发352亿,瑞幸还能翻身吗?
  • 投中网 · 48分钟前
  • 巴西卫生部长:在连遭四国拒绝后 中国伸出了援手
  • 新浪财经 · 56分钟前
  • 瑞幸可能退市 中概股池鱼遭殃
  • 创事记 · 1小时前
  • 瑞幸造假暴跌深埋158家持股机构 站台股东早已辞任或抛售套现
  • 一财网 · 1小时前

所属板块

食品加工
+2.20%
食品和烟类
+2.26%

热门股票

代码
价格
涨跌幅

PRPH 简况

ProPhase Labs, Inc. manufactures, markets and distributes a range of homeopathic and healthcare products. The Company is engaged in the research and development of over-the-counter (OTC) drugs and natural base health products, including supplements, personal care and cosmeceutical products. The Company's products include TK Supplements and ORXx Complete. TK Supplements consists of LEGENDZ XL, a male sexual enhancement; TRIPLE EDGE XL, a daily energy and stamina booster, and SUPER PROSTAFLOW plus, a supplement to support prostate and urinary health. The Company's OTC offerings include the ORXx cough/cold drops. Its consumer health customers include national wholesalers and distributors, as well as independent and chain food, drug and mass merchandise stores and pharmacies.
展开

微牛提供ProPhase Labs Inc(NASDAQ-PRPH)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的PRPH股票新闻,以帮助您做出投资决策。